"Just people saying that we're doing an easy fix, but like I said, it's not an easy fix, it's a stepping stone for where you're trying to go, Briseus said
In light of this potential significant safety issue, the development of Lotiglipron has been discontinued, meaning the drug did not progress to further clinical trial stages to evaluate its efficacy and safety
Most common are GI: nausea, decreased appetite, constipation, occasional diarrhea, and reflux typically mild to moderate and concentrated during dose escalation
Sold strictly for research purposes, not for clinical or human use
Additionally, there are Veterinarians that specialize in animal physical therapy and rehabilitation